The need for quality improvement in sweat testing infants after newborn screening for cystic fibrosis
- PMID: 20843526
- PMCID: PMC6326081
- DOI: 10.1016/j.jpeds.2010.07.053
The need for quality improvement in sweat testing infants after newborn screening for cystic fibrosis
Abstract
The proportion of insufficient sweat tests after positive newborn screening for cystic fibrosis was determined. Infants ≤ 3 months old had a mean (± standard deviation) rate of 7.2% (± 7.6) (range, 0% to 40%). Collection methods did not affect the rates. The high and variable rates indicate a need for quality improvement.
Copyright © 2010 Mosby, Inc. All rights reserved.
Conflict of interest statement
Conflict of interest:
References
-
- Parad RB, Comeau AM, Dorkin HL, Dovey M, Gerstle R, Martin T, O’Sullivan BP. Sweat testing infants detected by cystic fibrosis newborn screening. J Pediatr 2005. September;147(3 Suppl):S69–722005;40:64–67. - PubMed
-
- Farrell PM, Koscik RE. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis. Pediatrics 1996;97: 524–8 - PubMed
-
- LeGrys VA, Applequist R, Briscoe DR, Farrell P, Hickstein R, Lo SF et al.: Sweat Testing: Sample Collection and Quantitative Chloride Analysis: Approved Guideline- Third Edition. CLSI Document C34-A3 Wayne PA; Clinical and Laboratory Standards Institute; 2009.
-
- Eng W, LeGrys VA, Schechter MS, Laughon MM, Barker PM. Sweat testing in preterm and full-term infants less than 6 weeks of age. Pediatr Pulmonol 2005;40:64–67. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical